A retrospective study of Anakinra for pediatric patients with secondary hemophagocytic lymphohistiocytosis/ macrophage activation syndrome (MAS) associated with rheumatologic and non‐rheumatologic conditions
Latest Information Update: 20 Sep 2019
At a glance
- Drugs Anakinra (Primary)
- Indications Haemophagocytic lymphohistiocytosis
- Focus Therapeutic Use
Most Recent Events
- 20 Sep 2019 New trial record
- 12 Sep 2019 Results published in the Arthritis and Rheumatology.